
TEST
-
12/30/2019
PAION announces submission of New Drug Application for remimazolam by its licensee Hana Pharm in South Korea
-
11/20/2019
PAION announces submission of the Marketing Authorization Application for remimazolam in procedural sedation to the European Medicines Agency
-
11/05/2019
PAION AG invites to shareholder evening
-
09/11/2019
PAION announces attendance at three upcoming conferences
-
08/07/2019
PAION AG reports financial results for the first half-year of 2019
-
06/10/2019
FDA accepts filing of NDA for Remimazolam in the U.S.
-
05/22/2019
Annual general Meeting approves all agenda items and elects Dr. Leyck Dieken to the Supervisory Board
-
03/20/2019
PAION AG reports on fiscal year 2018
-
02/07/2019
PAION AG announces attendance at four upcoming conferences